Source: http://rrmedicine.ru/journal/article/865/
Timestamp: 2019-04-20 04:20:29+00:00

Document:
Ранняя диагностика фертильности после герниопластики различными способами остается трудной задачей. Данная работа посвящена исследованию матриксной метоллопротенкиназе-9 (ММР-9) в эякуляте после герниопластики. Клиническое исследование базировалось на материале результатов хирургического лечения паховой грыжи у 68 пациентов мужского пола в возрасте от 18 до 40 лет. Установлено достоверно повышенная концентрация ММР-9 в эякуляте после герниопластики уже на начальной стадии патологического процесса. Высокие показатели ММР-9 в эякуляте у пациентов оперированных по поводу паховой грыжи демонстрирует участие этого фермента в патологическом процессе после операции. Вместе с тем можно говорить, что не только химический состав, но и морфология поверхности имплантанта является важной характеристикой, определяемой реакцию организма на синтетический материал. Результаты исследования дает основание, что увеличение содержания ММР-9 в эякуляте можно говорить о наличии продолжительного воспалительного процесса. При оперативном лечении по методике Desarda без синтетических эндопротезов эти показатели в разы меньше. Определение метоллопротеинкиназы (ММР-9) в эякуляте может служить критерием выбора герниопластики у репродуктивных мужчин.
WHO estimates that in developed countries, the fertility level of the population is up to 20% [1, 3]. In the Russian Federation, more than 15% of couples of reproductive age are infertile and this problem is undoubtedly of state importance . According to the report of the Ministry of Health of the Republic of Dagestan in 2014, the incidence of infertility exceeds the average of 1.2 - 1.5 times. Such diseases as cryptorchidism, varicocele, inguinal hernia violate the reproductive function of men and 40 - 45% of infertility is due to male sterility (4). In the literature, there is no precise statistics on the percentage of infertility in men suffering from an inguinal hernia. In our country, a great number of operations on inguinal hernias are made. The introduction of synthetic materials in surgical practice in hernia repair has reduced the frequency of relapses up to 0.5 - 5% [5, 10]. In this regard, now the surgeons are facing a challenge of improving long-term results, including male infertility due to hernia carrier and hernia repair [1, 2, 8]. The studies revealed a negative effect as of hernia carrier on spermatogenesis and subsequent hernia repair [13, 29]. Various techniques for inguinal canal traditional plastics involve plastic inguinal canal local tissues with trauma, the movement of the elements of the spermatic cord. Internal or external inguinal ring is narrowed, the degree of narrowing is determined by the tip of the little finger of the surgeon and is therefore primitive. The spermatic cord is surrounded by a dense, stubborn scar tissue, which can also lead to disruption of the blood – and lymph drainage from testicles [2, 5]. In the postoperative period, when the plastic local tissues are likely to develop ischemic orchitis, is 2.5 - 3.2% . Violation of blood-testis barrier caused by ischemia can also stimulate the production of sperm antibodies, followed by the development of autoimmune orchitis with testicular dysfunction contralateral testis. It should be recognized that the problem of surgical treatment of inguinal hernias in men of reproductive age is far from being resolved. If we consider that postoperative infertility usually begins unnoticed, it is characterized by a prolonged period, small and hidden symptoms, the diagnosis in the early stages is a difficult task. Therefore, the problem of early diagnosis of postoperative fertility is important. Over the past decade, due to the development of molecular biology, biotechnology and genetic engineering has made a significant progress in the study of gene expression control mechanisms involved in physiological and pathological processes of the human body [4, 7]. Taking into account the lack of study of hormonal background after various options of prosthetic hernioplasty, it is of particular interest to study the activity of metalloproteinases [11, 12].
Objective. The study of the prognostic significance of the expression of MMP-9 in the ejaculate after prosthetic hernia repair.
Materials and methods of the research. This clinical research study is based upon the results of inguinal hernia repair in 68 male patients at the age from 18 to 40, hospitalized and operated by means of clinical bases of Continuing Medical Education and Professional Development of Dagestan State Medical University, National Interregional Multifield Hospital and Derbent Hospital during the period from 2010 to 2015. All the patients were engaged in the study with observance of the basic principles of Biomedical Ethics during the medical experiment performance. The Research Protocol was approved by the local Ethics Committee of the State-funded Educational Institution of Higher Vocational Education «Dagestan State Medical University».
1-st – 23 patients operated according to Lichtenstein.
2-nd – 23 patients operated according to Transabdominal Preperitoneal Hernia Repair method.
3-rd – 22 patients operated according to Desarda.
The control group included 5 patients undergoing their ejaculate diagnostics for infertility.
- age of patients between 18 and 40.
112 patients who were hospitalized for the indicated period of time fulfilled the above said criteria.
-refusal to participate or lack of informed consent statement for participate on at any stage of the study (44 patients).
Thus the selected subset of 68 patients corresponding to the inclusion criteria and not in conformity with exclusion criteria was formed.
Thus the 50 patient with unilateral hernia were identified and among them: 26 (38.2%) patients with sinister al hernia, 24 (35,3%) patients with dextral hernia and 10 (14,7%) patients with bilateral hernia of the total number of patients diagnosed with hernia. According to Nyhus classification of hernia types, 16 patients were diagnosed with the 1-st type , 22 patients – with the 2-nd type, 19 patients – with the 3-rd B type, and 11 patients – with the 4-th type.
All patients signed the informed consent statement for research study and the related therapy. All patients underwent a general clinical examination. 1 ml ejaculate samples were homogenized in Potter homogenizer in + 4,1°СM Tris Buffer (pH 8,0), 0,02 M EDTA. After 2 minutes of the centrifuge process, using the D-24Т centrifuge (Federal Republic of Germany) at 5000 rpm, the solvable forms of analyzed metalloproteinases-9 (ММР-9) were detected in supernatant fluid by enzyme-linked immune sorbent assay (ELISA) by applying conventional test-systems by R@DS (USA). The optical density measurement was conducted using the digital immune enzyme metric analyzer АТ-858 (Chine) at 450 mm wave length. The calibration line construction and calculate on of concentrations of ММР-9 analyzed values were performed in accordance with linear regression conditions in logarithmic coordinates. The postsurgical examination and ejaculate sampling took place 20 days past the surgery.
The Research Protocol was approved by the local Ethics Committee of Dagestan State Medical University of the Russian Federation Ministry of Health. The study was conducted in accordance with the National Standard of Russia. Before including into the study program, all the patients and donors had given their voluntary informed consent. The statistical processing of data was performed in «Statistica 7,0» software using the single-factor analysis of variance (Fisher's variance ratio). The differences were considered significant at р<0,05.
Spermogram values of patients operated according to Lichtenstein, n=8.
Spermogram values of patients operated according to TAPP, n=8.
Spermogram values of patients operated according to Desarda, n=9.
It is noted that the ММР-9 content in the ejaculate of patients operated for inguinal hernia repair is higher if compared with the control group (Table.2). The average ММР-9 level in the control group is 58.5 ng/ml and the ММР-9 level in patients operated for inguinal hernia repair ranges from 128.8 to 160.5 ng/ml. Thus the content of ММР-9 in the ejaculate fluid of patients operated for inguinal hernia repair is 2.8 times (р<0,05) higher than this value of the control group. It is of particular significance for this research that the patients operated for inguinal hernia repair according to Transabdominal Preperitoneal Hernia Repair and Lichtenstein methods have a much higher level of ММР-9 in their ejaculate even at the beginning of an inflammatory process.
ММР-9contentin ejaculate of examined patients (М+m).
It is determined that the ММР-9 level of patients operated according to Lichtenstein and Transabdominal Preperitoneal Hernia Repair methods with installation of the synthetic implant is reasonably higher than the MMP-9 level in the ejaculate of patients operated according to Desarda method with no implant installed (table 2). High ММР-9 concentrations in the ejaculate of patients after surgeries for inguinal hernia repair may be the evidence of the participation of this enzyme in post-surgical pathological processes. Moreover it would be reasonable to say that not only the chemical composition but also the morphology of implant surface is an important characteristic determining the body response to the foreign material. The results of our research give reasons to consider the elevated content of ММР-9 in the ejaculate as the evidence of a long-continued inflammatory process during the post-surgical period. The results of the study may be the evidence of the active involvement of ММР-9 in the developing chronical inflammatory processes marked with higher motility with the examined patients 6 months after the surgery with synthetic implants installed. Thus we can suppose the participation of ММР-9 in unpronounced processes with a breach of the blood-testis barrier induced by the long-lasting testicle ischemia. The advantage of this rather simple and noninvasive diagnostics method is that it provides a possibility to detect the beginning of testicle ischemia and the initial stages of smoldering inflammatory processes when no spermatic changes can be detected or these changes are still unremarkable. It is reasonable to take into consideration the fact that the late male in fertility is a disease with a difficultly of establishing diagnosis at early stage after the hernia repair surgery including implant installation. Thus it is important to perform early diagnostics of testicular abnormalities to begin the therapy and prevent the irreversible abnormal testicular changes. For many patients with timely drug treatment it is possible to slow down the disease progression and prevent the infertility establishment.
1. There was revealed a high content of metalloproteinases (MMP-9) in the ejaculate in patients after hernioplasty. The mean concentration of MMP-9 in the ejaculate control group was 58.5 ng/ml in patients after hernioplasty from 128.8 to 160.1 ng/ml.
2. MMP-9 level was significantly higher in patients’ ejaculate synthetic endoprosthesis and lower pull hernioplasty in Desard procedure. This makes it possible to use the indicator of the level of MMP-9 as a marker for the screening method of diagnostics of the initial symptoms of infertility.
3. MMP-9 concentration in ejaculate when bridged hernia repair can be a criterion of progression of testicular ischemia.
1. Аляев Ю.Г., Григорян В.А., Чолый М.Е Нарушение половой и репродуктивной функции у мужчин. М.: Медицина, 2006. 188 c.
2. Васильев В.И. К вопросу о ятрогенной обтурационной аспермии. Тезисы 1-го конгресса Профессиональной ассоциации андрологов России // Андрология и генитальная хирургия: Приложение. М., 2001. С. 72.
3. Винник Ю.С., Волова Ю.С., Винник Т.Г., Шишацкая Е.И. Влияние различных эндопротезов на состояние кровотока у пациентов оперированных по поводу паховых грыж // Креативная хирургия и онкология. 2014. № 4. С. 15-18.
4. Гамидов С.И., Тхагапсоева Р.А. Мужское бесплодие: современное состояние проблемы // Фарматека. 2009. № 9. С. 7-12.
5. Протасов А.В, Михалева Л.М., Смирнова Э.Д., Геворганян А.О. Сравнительные аспекты влияния современных сетчатых имплантов на состояние репродуктивных органов после моделирования герниопластики // Эндоскопическая хирургия. 2013. №1. С. 50-55.
6. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta. 2000. V. 1477. N 1-2. Pp. 267-283.
7. Kohn F.M,. Haid G.Anthological diagnostics. Urology. 2007. V. 46, N 11. Pp. 1557-1572.
8. Matzyk M.M., Lamb D.J. The biology of infertility: research advances a clinical challenges. Nat. Med. 2008. V. 45, N 11. Pp. 355-370.
9. Teppa-Garran A.D., Palacios-Torres A. Current evaluation of male infertility. Invest. Clin. 2004. V. 45, N 4. Pp. 355-370.
10. Fini M.E., Cook J.R., Mohan R., Brinkerhoft C.E. Regulation of matrix metallo-proteinase gene expression. Matrix metallo-proteinases. San Diego: Academic Press. 1998. Pp. 299-356.
11. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999. V. 274, N. 31. Pp. 21491-21494.
12. Shapiro S.D., Senior R.M. Matrix metalloproteinases: matrix degradation and more. American Journal of Respiratory Cell and Molecular Biology. 1999. V. 20. Pp. 1100- 10102.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V.